Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
*Correspondence: Yi Zhang, [email protected]
OPM guidance for plan year 2025 encourages FEHB carriers to implement real-time benefit tools to help enrollees view accurate pharmacy benefits, including member cost share
Glucose control The SURPASS studies enrolled populations that were similar in terms of baseline HbA1c levels, which ranged from 7.9 to 8.5% [2, 3, 59,60,61] and found a statistically significant reduction in HbA1c already at the 5 mg dose, demonstrating a greater efficacy of tirzepatide compared to placebo or active comparator [2, 3, 59,60,61]
Author Contributions All authors have reviewed the final manuscript prior to submission
These measures slow degradation but do not replace validated stability data
In addition to its HSA-mediated pharmacokinetic extension, albiglutide exhibits enhanced stability against enzymatic degradation by DPP-4
